PPD DEVELOPMENT LP
WILMINGTON, North Carolina
Total Received
$1.07B
Total Awards
43
State
North Carolina
Last Updated
Mar 26, 2026
Yearly Funding Trend
$919.9M24
$145.6M25
$3.1M26
Top 43 Awards to PPD DEVELOPMENT LP
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 26, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
CONT_AWD_HHSN272201700078C_7529_-NONE-_-NONE- NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $329,835,681 |
CONT_AWD_HHSN272201700004C_7529_-NONE-_-NONE- NIAID CLINICAL SITE MONITORING | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $136,003,422 |
CONT_AWD_75A50123C00045_7505_-NONE-_-NONE- EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI UNILATERAL MODIFICATION TO REFLECT PENDING DESCOPE AND DEOBLIGATION. | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | WILMINGTON, NC-07 | 2024 | $126,485,055 |
CONT_AWD_75A50124C00001_7505_-NONE-_-NONE- BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HOST-DIRECTED THERAPEUTIC CAN… | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | WILMINGTON, NC-07 | 2024 | $117,399,278 |
CONT_AWD_75N93022F00002_7529_75N93021D00035_7529 "COVID 19" COMPLETION OF ACTIV 2 STUDY | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2025 | $82,531,927 |
CONT_AWD_75N93024F00001_7529_75N93021D00035_7529 NIAID CLINICAL SITE MONITORING (NCSM) | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $73,196,564 |
CONT_AWD_75N93022F00001_7529_75N93021D00035_7529 SUPPORT SERVICES FOR ACTIV 2 | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2025 | $34,618,532 |
CONT_AWD_75N93022C00014_7529_-NONE-_-NONE- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC) | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $28,578,960 |
CONT_AWD_HHSN272201200004C_7529_-NONE-_-NONE- NIAID DAIT CLINICAL SITE MONITORING CENTER | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2025 | $27,247,204 |
ASST_NON_U01AI178756_075 PPDS APPLICATION FOR THE TRANSPLANTATION STATISTICAL AND CLINICAL COORDINATING CENTER (T-SCCC) (U01 CLINICAL TRIAL NOT ALLOWED) - PROJECT SUMMARY/ABSTRACT TO SUPPORT DAIT'S EFFORT… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NC-90 | 2024 | $26,732,375 |
CONT_AWD_HHSN272201200002C_7529_-NONE-_-NONE- REGULATORY MANAGEMENT CENTER | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $22,043,479 |
CONT_AWD_75N93022C00001_7529_-NONE-_-NONE- REGULATORY MANAGEMENT CENTER (RMC) | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $17,426,404 |
CONT_AWD_75N93024F00002_7529_75N93021D00035_7529 EOI::RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $17,155,112 |
CONT_AWD_75N93019F00131_7529_HHSN272201700002I_7529 DAIDS ONSITE MONITORING FOR 1 PHASE III STUDY: A5300B/PHOENIX | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $5,758,524 |
CONT_AWD_75N93026F00001_7529_75N93021D00035_7529 DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX) | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2026 | $3,092,829 |
CONT_AWD_75N93023F00001_7529_75N93022D00017_7529 EPCTU - TO IMPLEMENT PHASE 0 TO PHASE II CLINICAL TRIALS, INCLUDING PROOF-OF-CONCEPT STUDIES IN HEALTHY AND DISEASED HUMAN POPULATIONS, DOMESTICALLY AND INTERNATIONALLY, AIDED BY… | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $2,791,811 |
CONT_AWD_75N95024F00001_7529_HHSN271201600005I_7529 SAHN SINGLE ASCENDING DOSE (SAD) PHASE I STUDY (4ET1103) | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $2,773,098 |
CONT_AWD_75D30121C11269_7523_-NONE-_-NONE- TBTC MONITORING | Department of Health and Human Services Centers for Disease Control and Prevention | — | WILMINGTON, NC-07 | 2024 | $1,925,432 |
CONT_AWD_75N95019F00089_7529_HHSN271201600005I_7529 TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF T… | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $1,820,177 |
CONT_AWD_75N95018F00002_7529_HHSN271201600005I_7529 PETRUKHIN PHASE I CLINICAL TRIAL FOR DEVELOPMENT OF NEUROTHERAPEUTICS | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $1,737,263 |
CONT_AWD_75A50121P00004_7505_-NONE-_-NONE- ESTABLISHMENT OF HIGH THROUGHPUT SARS-COV-2 BINDING ANTIBODY IMMUNOASSAY CAPABILITY AND TESTING OF HUMAN SERUM SAMPLES: MODIFIED TO REMOVE REQUIREMENTS AND FUNDING | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | WILMINGTON, NC-07 | 2024 | $1,422,550 |
CONT_AWD_0011_9700_W81XWH15D0038_9700 OPTION 1 - TRAINING | Department of Defense Department of the Army | — | WILMINGTON, NC-07 | 2024 | $1,346,058 |
CONT_AWD_75N95022C00036_7529_-NONE-_-NONE- EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI TERMINATION FOR CONVENIENCE. CLINICAL RESEARCH AND STUDY MONI… | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $1,226,376 |
CONT_AWD_75N93022F00001_7529_75N93022D00017_7529 TASK AREA A: ADMINISTRATION AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $905,501 |
CONT_AWD_75F40124C00117_7524_-NONE-_-NONE- FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE | Department of Health and Human Services Food and Drug Administration | — | WILMINGTON, NC-07 | 2024 | $724,461 |
CONT_AWD_HHSN271201700007A_7529_-NONE-_-NONE- STUDY AND SITE MONITORING SERVICES | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $696,693 |
CONT_AWD_75N92019C00005_7529_-NONE-_-NONE- CLINICAL SITE AND STUDY MONITORING SUPPORT SERVICES FOR THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE'S HYPERTENSION OUTCOMES FOR T4 RESEARCH WITHIN LOWER MIDDLE-INCOME COUNTRIES… | Department of Health and Human Services National Institutes of Health | — | BETHESDA, MD-08 | 2025 | $654,561 |
CONT_AWD_W81XWH18F0195_9700_W81XWH15D0038_9700 HIV COHORT STUDY | Department of Defense Defense Health Agency | — | — | 2025 | $516,111 |
CONT_AWD_75F40124C00134_7524_-NONE-_-NONE- NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO 04/13/2026. | Department of Health and Human Services Food and Drug Administration | — | WILMINGTON, NC-07 | 2024 | $497,579 |
CONT_AWD_75N95018F00001_7529_HHSN271201800007I_7529 PPD DEVELOPMENT LP:1106692 [18-007540]. MODIFICATION TO (1) CHANGE THE PERIOD OF PERFORMANCE; (2) ADD OPTIONAL TASKS TO THE STATEMENT OF WORK; AND (3) CHANGE THE TASK ORDER PRICE. | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $347,500 |
CONT_AWD_75N95024F00001_7529_75N95023D00011_7529 RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/16/2029. | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $324,420 |
CONT_AWD_75N95024F00002_7529_HHSN271201600005I_7529 PHASE I RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $305,772 |
CONT_AWD_75F40123C00198_7524_-NONE-_-NONE- ASSESSING CLINICAL SITE READINESS: A FRAMEWORK TO SUPPORT ENROLLMENT OF UNDER-REPRESENTED MINORITIES IN MEDICAL DEVICE CLINICAL TRIALS (FY23C1FWP6) | Department of Health and Human Services Food and Drug Administration | — | WILMINGTON, NC-07 | 2024 | $235,056 |
CONT_AWD_75N95024F00001_7529_75N95022D00020_7529 CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. REGULATORY PATHWAY AND MARKET ACCESS SUPPORT. TASK ORDER… | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $188,866 |
CONT_AWD_75N95023F00001_7529_75N95022D00020_7529 REGULATORY CONSULTING ASSISTANCE FOR MEDICAL DEVICE DEVELOPER. RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. TASK ORDER 02. 09/15/2023 - 12/31/2024. | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $64,107 |
CONT_AWD_75N95025F00001_7529_75N95022D00020_7529 TASK ORDER75N95025F00001 TO4 BLUEPRINT MEDTECH PREPARATION OF PRE-SUBMISSION SUPPORT FOR PILOT PARTICIPANT. | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2025 | $5,334 |
CONT_IDV_47QRCA25DU259_4732 ONE ACQUISITION SOLUTION FOR INTEGRATED SERVICES PLUS (OASIS+) UNRESTRICTED MULTIPLE AGENCY CONTRACT (MAC) | General Services Administration Federal Acquisition Service | — | — | 2025 | $2,500 |
CONT_IDV_HHSN271201800007I_7529 PPD - CRO SUPPORT FOR NCATS BIOANALYTICAL METHOD DEVELOPMENT FOR BIOLOGICS | Department of Health and Human Services National Institutes of Health | — | — | 2024 | $0 |
CONT_IDV_75N95022D00020_7529 CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. ORDERING PERIOD: 9/22/2022 - 9/21/2027. N02DA-22-1235. | Department of Health and Human Services National Institutes of Health | — | — | 2024 | $0 |
CONT_IDV_75N93022D00017_7529 EARLY PHASE CLINICAL TRIAL UNITS (EPCTU) | Department of Health and Human Services National Institutes of Health | — | — | 2024 | $0 |
CONT_IDV_75N95023D00011_7529 RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. ORDERING PERIOD: 09/01/2023 - 8/31/2028. (BPMT) INITIATIVE. | Department of Health and Human Services National Institutes of Health | — | — | 2025 | $0 |
CONT_IDV_HT001122D0040_9700 OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT | Department of Defense Defense Health Agency | — | — | 2025 | $0 |
CONT_IDV_75N93021D00035_7529 COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS | Department of Health and Human Services National Institutes of Health | — | — | 2026 | $0 |
Top 43 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→1234567
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)$474.3M
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$346.4M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$161.1M
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY$55.0M
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES$2.6M
OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES$1.9M
RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES$498K
Federal Programs (CFDA)
View All→Source: USAspending.gov · All Recipients · North Carolina